Scientists at the ALS Therapy Development Institute are conducting research on this small molecule to determine whether or not it can be used as an effective treatment for ALS by addressing the dysfunctional UPR in motor neurons of PALS.
We are working to develop a formulation strategy for this small molecule so that it can be effectively screened using preclinical models of ALS.
Topics in the Pipeline